Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Cyr61/CCN1 affects the integrin-mediated migration of prostate cancer cells (PC-3) in vitro.
Int J Clin Pharmacol Ther. 2013 Jan;51(1):47-50. doi: 10.5414/cpp51047.
Int J Clin Pharmacol Ther. 2013.
PMID: 23259998
Free article.
No abstract available.
Cyr61 is a target for heparin in reducing MV3 melanoma cell adhesion and migration via the integrin VLA-4.
Schmitz P, Gerber U, Schütze N, Jüngel E, Blaheta R, Naggi A, Torri G, Bendas G.
Schmitz P, et al. Among authors: jungel e.
Thromb Haemost. 2013 Nov;110(5):1046-54. doi: 10.1160/TH13-02-0158. Epub 2013 Sep 5.
Thromb Haemost. 2013.
PMID: 24009013
Item in Clipboard
Latent heparanase facilitates VLA-4-mediated melanoma cell binding and emerges as a relevant target of heparin in the interference with metastatic progression.
Gerber U, Hoß SG, Shteingauz A, Jüngel E, Jakubzig B, Ilan N, Blaheta R, Schlesinger M, Vlodavsky I, Bendas G.
Gerber U, et al. Among authors: jungel e.
Semin Thromb Hemost. 2015 Mar;41(2):244-54. doi: 10.1055/s-0035-1544229. Epub 2015 Feb 15.
Semin Thromb Hemost. 2015.
PMID: 25682080
Item in Clipboard
sE-cadherin is upregulated in serum of patients with renal cell carcinoma and promotes tumor cell dissemination in vitro.
Tsaur I, Hüsch T, Jüngel E, Schneider F, Schneider M, Haferkamp A, Thomas C, Lieb V, Wach S, Taubert H, Chun FK, Blaheta RA.
Tsaur I, et al. Among authors: jungel e.
Urol Oncol. 2019 Jun;37(6):355.e1-355.e9. doi: 10.1016/j.urolonc.2019.03.001. Epub 2019 Apr 18.
Urol Oncol. 2019.
PMID: 31005422
Item in Clipboard
Experimental imaging in orthotopic renal cell carcinoma xenograft models: comparative evaluation of high-resolution 3D ultrasonography, in-vivo micro-CT and 9.4T MRI.
Linxweiler J, Körbel C, Müller A, Jüngel E, Blaheta R, Heinzelmann J, Stöckle M, Junker K, Menger MD, Saar M.
Linxweiler J, et al. Among authors: jungel e.
Sci Rep. 2017 Oct 27;7(1):14249. doi: 10.1038/s41598-017-14759-1.
Sci Rep. 2017.
PMID: 29079842
Free PMC article.
Item in Clipboard
AR-V7 Protein Expression in Circulating Tumour Cells Is Not Predictive of Treatment Response in mCRPC.
Erb HHH, Sparwasser P, Diehl T, Hemmerlein-Thomas M, Tsaur I, Jüngel E, Sommer U, Baretton GB, Haferkamp A, Neisius A, Thomas C.
Erb HHH, et al. Among authors: jungel e.
Urol Int. 2020;104(3-4):253-262. doi: 10.1159/000504416. Epub 2020 Jan 17.
Urol Int. 2020.
PMID: 31955172
Item in Clipboard
PIAS1 is not suitable as a urothelial carcinoma biomarker protein and pharmacological target.
Erb HHH, Ebert M, Kuhn R, Donix L, Haferkamp A, Seed RI, Jüngel E.
Erb HHH, et al. Among authors: jungel e.
PLoS One. 2019 Oct 22;14(10):e0224085. doi: 10.1371/journal.pone.0224085. eCollection 2019.
PLoS One. 2019.
PMID: 31639157
Free PMC article.
Item in Clipboard
Cite
Cite